Interim Results for the six months to 30 June 2000
Post navigation
←
Clinical Trials, Scientific and Manufacturing update
ReGen Therapeutics strength organisation ahead of trial results and appoints Ernst and Young as nominated Adviser
→
Home
About Us
Our History
Directors
Products & Research
Colostrinin as a nutraceutical
Pharmaceuticals – Peptides
Pharmaceuticals – Zolpidem
Presentations
News
Announcements
Events Calendar
Email News Alerts
Contact Us
